How would a focus of anaplastic carcinoma change your approach to adjuvant therapy for a premenopausal patient with stage IC mucinous borderline tumor of the ovary?  

Patient is s/p USO only, would you take her back to remove the contralateral ovary?



Answer from: at Academic Institution